Jin Rong Jie·2025-12-10 14:00Core Viewpoint - The company, Shiyao Innovation Pharmaceutical Co., Ltd. (stock code: 300765.SZ), has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as its sole sponsor. The company focuses on the research, production, and commercialization of biopharmaceuticals, functional raw materials, and health foods [1]. Group 1: Company Overview - Shiyao Innovation has maintained its position as the world's largest producer of synthetic caffeine by revenue and shipment volume from 2020 to 2024, according to Frost & Sullivan [1]. - Since its establishment in 2006, the company has concentrated on the research and production of high-quality caffeine, primarily used as a food additive in functional beverages [1]. Group 2: Market Presence - As of the latest feasible date (December 1, 2025), the company's products have been sold in 65 countries and regions globally, with North America and Europe being its main markets [1]. - The company has established solid partnerships with leading international beverage industry clients, including Coca-Cola (since 2006), PepsiCo (since 2007), and Red Bull GmbH (since 2008), serving as their global caffeine supplier [1].